SEC Form 4 · accession 0001127602-16-054694
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Christopher Causey
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 3, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 2, 2016 | M | 750 | $51.77 | A | 1,855 | D | |
| Common Stock | Jun 2, 2016 | D | 750 | $121.03 | D | 1,105 | D | |
| Common Stock | holding | — | — | — | 0 | I | By Ugma Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $51.77 | Jun 2, 2016 | M | 750 | D | Jun 28, 2011 | Jun 28, 2020 | Common Stock | 750 | 10,500 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.